C

Catalyst Pharmaceuticals

D
CPRX
USD
0.94
(4.6056%)
Market Closed
47,959.00
Volume
1.565
EPS
-
Div Yield
38.125
P/E
2,533,986,600.95
Market Cap
Today
4.6056%
1 Week
5.224%
1 Month
6.803%
6 Months
30.302%
12 Months
67.846%
Year To Date
27.159%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ADMP
(%)
USD
A
ALKS
0.52
(1.8671%)
USD
AMGN
AMGN
3.02
(0.9071%)
USD
A
ANIK
-0.15
(-0.588%)
USD
A
AVDL
-0.05
(-0.3666%)
USD
B
BHC
0.16
(1.995%)
USD
E
EYEN
0.0034
(0.6692%)
USD

Title:
Catalyst Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Do you need help or have a question?
Contact Us